⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for An Open Study Assessing the Safety and Tolerability of U3-1784

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: An Open Study Assessing the Safety and Tolerability of U3-1784

Official Title: A Phase 1, Open-label, Two-part, Safety and Tolerability Study of U3-1784 in Patients With Advanced Solid Tumours

Study ID: NCT02690350

Interventions

U3-1784

Study Description

Brief Summary: The main objectives of the trial are: * To evaluate the safety and tolerability of U3-1784 in patients with advanced solid tumours * To determine the maximum tolerated dose (MTD) and or establish the safety and tolerability of the maximum administered dose (MAD) of U3-1784

Detailed Description:

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

, Glasgow, Lanarkshire, United Kingdom

The Royal Marsden Hospital, Sutton, Surrey, United Kingdom

Guy's Hospital, London, , United Kingdom

The Christie NHS Foundation Trust, Manchester, , United Kingdom

Contact Details

Name: Alberto Martinez, PhD

Affiliation: Daiichi Sankyo UK Ltd.

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: